Skip header and navigation

11 records – page 1 of 1.

Birth control pills

https://libcat.nshealth.ca/en/permalink/chpams36525
Nova Scotia Health Authority. Nova Scotia Women's Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
0171
Available Online
View Pamphlet
Birth control pills work to prevent pregnancy by stopping you from ovulating, thickening the mucus made by your cervix, and changing the lining of your uterus. This pamphlet explains how well the pill works, when it starts working, pros and cons, how to take it, what can change how well it works, instructions for missed pills, and possible side effects (as well as serious ones to be aware of). The pill is not prescribed to women over 35 who smoke due to the risks involved. The pill will not pro…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Women's Choice Clinic
Alternate Title
The pill
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Ovulation Inhibition
Contraception - methods
Subjects (LCSH)
Oral contraceptives
Contraception
Abstract
Birth control pills work to prevent pregnancy by stopping you from ovulating, thickening the mucus made by your cervix, and changing the lining of your uterus. This pamphlet explains how well the pill works, when it starts working, pros and cons, how to take it, what can change how well it works, instructions for missed pills, and possible side effects (as well as serious ones to be aware of). The pill is not prescribed to women over 35 who smoke due to the risks involved. The pill will not protect you against sexually transmitted infections (STIs). The French version of this pamphlet 2027, "La pilule contraceptive", is also available.
Responsibility
Prepared by: Nova Scotia Women's Choice Clinic
Pamphlet Number
0171
Less detail

Buprenorphine for opioid use disorder

https://libcat.nshealth.ca/en/permalink/chpams37561
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2267
Available Online
View Pamphlet
Buprenorphine is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a longer time. This pamphlet explains how to take this medication, how fast buprenorphine starts to work, how your health care team will find the right dose for you, and how long you will need to take buprenorphine. Information on whether buprenorphine interacts with any other medications and possible side effects is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Buprenorphine
Opioid-Related Disorders - therapy
Subjects (LCSH)
Buprenorphine
Opioid abuse
Specialty
Medications
Abstract
Buprenorphine is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a longer time. This pamphlet explains how to take this medication, how fast buprenorphine starts to work, how your health care team will find the right dose for you, and how long you will need to take buprenorphine. Information on whether buprenorphine interacts with any other medications and possible side effects is included.
Responsibility
Prepared by: Pharmacy Services, Aberdeen Hospital
Pamphlet Number
2267
Less detail

Déclenchement artificiel du travail

https://libcat.nshealth.ca/en/permalink/chpams35877
Nova Scotia Health Authority. Women and Children's Health Unit. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1813
Available Online
View Pamphlet
On parle de déclenchement artificiel du travail quand une méthode ou un médicament est utilisé pour commencer le travail avant qu’il ne commence par lui-même. Le but du déclenchement artificiel du travail est l’accouchement vaginal. Le présent dépliant explique pourquoi on vous offre le déclenchement artificiel du travail, la façon dont il est fait, le temps nécessaire et ce qui se passe à votre arrivée à l’hôpital. On traite aussi de ce qu’il faut faire si le déclenchement artificiel du travai…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Health Unit
Alternate Title
Induction of labour
Induction of labor
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
On parle de déclenchement artificiel du travail quand une méthode ou un médicament est utilisé pour commencer le travail avant qu’il ne commence par lui-même. Le but du déclenchement artificiel du travail est l’accouchement vaginal. Le présent dépliant explique pourquoi on vous offre le déclenchement artificiel du travail, la façon dont il est fait, le temps nécessaire et ce qui se passe à votre arrivée à l’hôpital. On traite aussi de ce qu’il faut faire si le déclenchement artificiel du travail est reporté.
This pamphlet is a French translation of "Induction of labour" pamphlet 1813. Induction of labour is when a method or medication is used to start labour before it starts on its own. The goal of induction is to have a vaginal birth. This pamphlet explains why you are being offered induction, how it is done, how long it takes, and what will happen when you come to the hospital. What to do if your induction is postponed is also discussed.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1813
Less detail

Décollement postérieur du vitré (DPV)

https://libcat.nshealth.ca/en/permalink/chpams37469
Nova Scotia Health Authority. Eye Care Centre. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2162
Available Online
View Pamphlet
Le décollement postérieur du vitré (DPV) est un problème oculaire fréquent pouvant entraîner l’apparition de corps flottants (points ou taches) et d’éclairs. Le DPV se produit lorsque le gel qui se trouve à l’arrière de l’œil commence avec l’âge à rétrécir et devient liquide. Ce gel, appelé humeur vitrée, est normalement attaché à la membrane de l’œil, c’est-à-dire à la rétine. Lorsque l’humeur vitrée rétrécit, elle peut se détacher à certains endroits de la rétine. Ce dépliant présente les cau…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Eye Care Centre
Alternate Title
Posterior vitreous detachment (PVD)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Vitreous Detachment
Subjects (LCSH)
Vitreous humor
Specialty
Ophthalmology
Abstract
Le décollement postérieur du vitré (DPV) est un problème oculaire fréquent pouvant entraîner l’apparition de corps flottants (points ou taches) et d’éclairs. Le DPV se produit lorsque le gel qui se trouve à l’arrière de l’œil commence avec l’âge à rétrécir et devient liquide. Ce gel, appelé humeur vitrée, est normalement attaché à la membrane de l’œil, c’est-à-dire à la rétine. Lorsque l’humeur vitrée rétrécit, elle peut se détacher à certains endroits de la rétine. Ce dépliant présente les causes du DPV, ses symptômes ainsi que sa détection.
This pamphlet is a French translation of the English pamphlet 1761, "Posterior Vitreous Detachment (PVD)". Posterior vitreous detachment (PVD) is a common eye condition that can cause floaters (dots or spots) and flashes of light in your vision. PVD happens when a gel at the back of the eye starts to shrink with age and becomes liquid. This gel, called the vitreous humor, is normally attached to the ‘film’ of the eye, called the retina. When the vitreous humor shrinks and pulls away from the retina, it can detach itself (come apart from) from the retina in some places. This pamphlet explains what causes PVD, the symptoms of PVD, and how PVD is diagnosed and treated.
Responsibility
Prepared by: Eye Care Centre
Images by: Dr. Darrell Lewis
Pamphlet Number
2162
Less detail
Nova Scotia Health Authority. Nova Scotia Women's Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
0112
Available Online
View Pamphlet
Depo-Provera is an injectable (given by needle) form of hormones similar to the natural progesterone made by your ovaries each month. It is used to prevent pregnancy. This pamphlet explains how Depo-Provera works, how well it works, how to get it, when it starts working, pros and cons, who should not take it, and certain things to remember when taking it. Depo-Provera will not protect you against sexually transmitted infections (STIs). A list of resources is provided if you have any questions. …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Women's Choice Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Medroxyprogesterone Acetate
Contraception - methods
Subjects (LCSH)
Medroxyprogesterone
Contraception
Abstract
Depo-Provera is an injectable (given by needle) form of hormones similar to the natural progesterone made by your ovaries each month. It is used to prevent pregnancy. This pamphlet explains how Depo-Provera works, how well it works, how to get it, when it starts working, pros and cons, who should not take it, and certain things to remember when taking it. Depo-Provera will not protect you against sexually transmitted infections (STIs). A list of resources is provided if you have any questions. The French version of this pamphlet 2016, "Depo-Provera", is also available.
Responsibility
Prepared by: Nova Scotia Women's Choice Clinic
Pamphlet Number
0112
Less detail
Nova Scotia Health Authority. Nova Scotia Women's Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
2016
Available Online
View Pamphlet
Depo-Provera est un produit hormonal injectable similaire à la progestérone naturelle produite par les ovaires tous les mois. Il sert à prévenir les grossesses. Le dépliant explique comment Depo-Provera travaille, quelle est son efficacité, comment se le procurer, quand il commence à agir, quels sont les avantages et les désavantages de prendre Depo-Provera, quelles sont les personnes qui ne devraient pas prendre ce produit hormonal et quelles sont les choses à ne pas oublier quand vous le pren…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Women's Choice Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
French
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Medroxyprogesterone Acetate
Contraception - methods
Subjects (LCSH)
Medroxyprogesterone
Contraception
Abstract
Depo-Provera est un produit hormonal injectable similaire à la progestérone naturelle produite par les ovaires tous les mois. Il sert à prévenir les grossesses. Le dépliant explique comment Depo-Provera travaille, quelle est son efficacité, comment se le procurer, quand il commence à agir, quels sont les avantages et les désavantages de prendre Depo-Provera, quelles sont les personnes qui ne devraient pas prendre ce produit hormonal et quelles sont les choses à ne pas oublier quand vous le prenez Depo-Provera ne vous protège pas contre les infections transmissibles sexuellement. D’autres ressources sont mentionnées au cas où vous auriez des questions.
This is a French translation of the English pamphlet 0112, "Depo-Provera". Depo-Provera is an injectable (given by needle) form of hormones similar to the natural progesterone made by your ovaries each month. It is used to prevent pregnancy. This pamphlet explains how Depo-Provera works, how well it works, how to get it, when it starts working, pros and cons, who should not take it, and certain things to remember when taking it. Depo-Provera will not protect you against sexually transmitted infections (STIs). A list of resources is provided if you have any questions.
Responsibility
Prepared by: Nova Scotia Women's Choice Clinic
Pamphlet Number
2016
Less detail

Induction of labour

https://libcat.nshealth.ca/en/permalink/chpams35818
Nova Scotia Health Authority. Women and Children's Health. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1768
Available Online
View Pamphlet
Induction of labour is when a method or medication is used to start labour before it starts on its own. The goal of induction is to have a vaginal birth. This pamphlet explains why you are being offered induction, how it is done, how long it takes, and what will happen when you come to the hospital. What to do if your induction is postponed is also discussed. The French version of this pamphlet 1813, "Déclenchement artificiel du travail", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Health
Alternate Title
Induction of labor
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
Induction of labour is when a method or medication is used to start labour before it starts on its own. The goal of induction is to have a vaginal birth. This pamphlet explains why you are being offered induction, how it is done, how long it takes, and what will happen when you come to the hospital. What to do if your induction is postponed is also discussed. The French version of this pamphlet 1813, "Déclenchement artificiel du travail", is also available.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1768
Less detail

Methadone for opioid use disorder

https://libcat.nshealth.ca/en/permalink/chpams37548
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2259
Available Online
View Pamphlet
Methadone is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a long time. This pamphlet explains how to take this medication, how fast methadone starts to work, how your health care team will find the right dose for you, and how long you will need to take methadone. Information about interactions with other medications and possible side effects is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Methadone
Subjects (LCSH)
Methadone hydrochloride
Specialty
Medications
Abstract
Methadone is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a long time. This pamphlet explains how to take this medication, how fast methadone starts to work, how your health care team will find the right dose for you, and how long you will need to take methadone. Information about interactions with other medications and possible side effects is included.
Responsibility
Prepared by: Pharmacy Services, Aberdeen Hospital
Pamphlet Number
2259
Less detail

La pilule contraceptive

https://libcat.nshealth.ca/en/permalink/chpams36608
Nova Scotia Health Authority. Nova Scotia Women's Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
2027
Available Online
View Pamphlet
La pilule contraceptive empêche la grossesse en arrêtant le cycle d’ovulation, en provoquant l’épaississement des sécrétions (mucus) du col de l’utérus et en modifiant la paroi intérieure de l’utérus. Le livret explique le fonctionnement de la pilule, le moment où elle commence son travail, ses avantages et ses inconvénients, la manière de la prendre et ce qui peut modifier son efficacité; on explique quoi faire si on oublie de prendre la pilule, les effets secondaires possibles, de même que le…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Women's Choice Clinic
Alternate Title
Birth control pills
The pill
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
French
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Ovulation Inhibition
Contraception - methods
Subjects (LCSH)
Oral contraceptives
Contraception
Abstract
La pilule contraceptive empêche la grossesse en arrêtant le cycle d’ovulation, en provoquant l’épaississement des sécrétions (mucus) du col de l’utérus et en modifiant la paroi intérieure de l’utérus. Le livret explique le fonctionnement de la pilule, le moment où elle commence son travail, ses avantages et ses inconvénients, la manière de la prendre et ce qui peut modifier son efficacité; on explique quoi faire si on oublie de prendre la pilule, les effets secondaires possibles, de même que les effets secondaires graves qu’il faut connaître. La pilule contraceptive n’est pas prescrite aux fumeuses de 35 ans et plus compte tenu des risques. La pilule ne vous protège pas contre les infections transmissibles sexuellement.
This is a French translation of the English pamphlet 0171, "Birth Control Pills". Birth control pills work to prevent pregnancy by stopping you from ovulating, thickening the mucus made by your cervix, and changing the lining of your uterus. This pamphlet explains how well the pill works, when it starts working, pros and cons, how to take it, what can change how well it works, instructions for missed pills, and possible side effects (as well as serious ones to be aware of). The pill is not prescribed to women over 35 who smoke due to the risks involved. The pill will not protect you against sexually transmitted infections (STIs).
Responsibility
Prepared by: Nova Scotia Women's Choice Clinic
Pamphlet Number
2027
Less detail

Posterior vitreous detachment (PVD)

https://libcat.nshealth.ca/en/permalink/chpams35808
Nova Scotia Health Authority. Eye Care Centre. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1761
Available Online
View Pamphlet
Posterior vitreous detachment (PVD) is a common eye condition that can cause floaters (dots or spots) and flashes of light in your vision. PVD happens when your vitreous humor (a gel at the back of your eye) starts to shrink and becomes liquid. A healthy vitreous humour is attached to a part of your eye called the retina. When the vitreous humour shrinks, it can detach (come apart) from parts of the retina. This pamphlet explains what causes PVD, the symptoms of PVD, and how PVD is diagnosed an…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Eye Care Centre
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Vitreous Detachment
Subjects (LCSH)
Vitreous humor
Specialty
Ophthalmology
Abstract
Posterior vitreous detachment (PVD) is a common eye condition that can cause floaters (dots or spots) and flashes of light in your vision. PVD happens when your vitreous humor (a gel at the back of your eye) starts to shrink and becomes liquid. A healthy vitreous humour is attached to a part of your eye called the retina. When the vitreous humour shrinks, it can detach (come apart) from parts of the retina. This pamphlet explains what causes PVD, the symptoms of PVD, and how PVD is diagnosed and treated. Information about follow-up care is given. The French version of this pamphlet 2162, "Décollement postérieur du vitré (DPV)," is also available.
Responsibility
Prepared by: Eye Care Centre; Illustration by: Dr. Darrell Lewis
Pamphlet Number
1761
Less detail

Quitting smoking to lower your risk of cervical cancer

https://libcat.nshealth.ca/en/permalink/chpams37302
Nova Scotia Health Authority. Department of Obstetrics and Gynecology. Division of Gynaecologic Oncology. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2167
Available Online
View Pamphlet
Cervical cancer is cancer that starts in the cervix. The cervix is the lower part of the uterus (womb) that opens at the top of the vagina. This pamphlet explains how smoking increases your chance of getting cervical cancer, other reasons to quit smoking, what nicotine replacement therapy (NRT) is and how much it will cost, why e-cigarettes are not recommended, medications that are available to help you quit smoking, and other options to quit smoking. Tips for quitting smoking and a list of res…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Department of Obstetrics and Gynecology. Division of Gynaecologic Oncology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Smoking Cessation
Uterine Cervical Neoplasms - prevention & control
Subjects (LCSH)
Smoking cessation
Cervix uteri--Cancer--Prevention
Specialty
Gynecology
Abstract
Cervical cancer is cancer that starts in the cervix. The cervix is the lower part of the uterus (womb) that opens at the top of the vagina. This pamphlet explains how smoking increases your chance of getting cervical cancer, other reasons to quit smoking, what nicotine replacement therapy (NRT) is and how much it will cost, why e-cigarettes are not recommended, medications that are available to help you quit smoking, and other options to quit smoking. Tips for quitting smoking and a list of resources are also provided.
Responsibility
Prepared by: Department of Obstetrics and Gynecology: Division of Gynaecologic Oncology
Pamphlet Number
2167
Less detail

11 records – page 1 of 1.